全文获取类型
收费全文 | 1868篇 |
免费 | 145篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 29篇 |
妇产科学 | 15篇 |
基础医学 | 249篇 |
口腔科学 | 25篇 |
临床医学 | 180篇 |
内科学 | 427篇 |
皮肤病学 | 30篇 |
神经病学 | 350篇 |
特种医学 | 146篇 |
外科学 | 148篇 |
综合类 | 25篇 |
一般理论 | 2篇 |
预防医学 | 171篇 |
眼科学 | 25篇 |
药学 | 132篇 |
中国医学 | 1篇 |
肿瘤学 | 51篇 |
出版年
2022年 | 15篇 |
2021年 | 24篇 |
2020年 | 15篇 |
2019年 | 25篇 |
2018年 | 31篇 |
2017年 | 33篇 |
2016年 | 35篇 |
2015年 | 34篇 |
2014年 | 34篇 |
2013年 | 59篇 |
2012年 | 86篇 |
2011年 | 98篇 |
2010年 | 39篇 |
2009年 | 38篇 |
2008年 | 70篇 |
2007年 | 67篇 |
2006年 | 74篇 |
2005年 | 74篇 |
2004年 | 66篇 |
2003年 | 67篇 |
2002年 | 76篇 |
2001年 | 51篇 |
2000年 | 73篇 |
1999年 | 61篇 |
1998年 | 36篇 |
1997年 | 35篇 |
1996年 | 45篇 |
1995年 | 26篇 |
1994年 | 33篇 |
1993年 | 43篇 |
1992年 | 43篇 |
1991年 | 35篇 |
1990年 | 36篇 |
1989年 | 48篇 |
1988年 | 35篇 |
1987年 | 34篇 |
1986年 | 36篇 |
1985年 | 37篇 |
1984年 | 23篇 |
1983年 | 21篇 |
1982年 | 14篇 |
1979年 | 17篇 |
1978年 | 15篇 |
1975年 | 13篇 |
1972年 | 11篇 |
1971年 | 12篇 |
1970年 | 14篇 |
1969年 | 13篇 |
1968年 | 13篇 |
1966年 | 10篇 |
排序方式: 共有2031条查询结果,搜索用时 62 毫秒
1.
The following recommendations of the Neonatal Hemostasis Subcommittee of the Scientific and Standardization Committee of the ISTH for the management of neonatal immune thrombocytopenia were prepared by the working party on neonatal immune thrombocytopenia. Evaluation, diagnosis, and treatment of the mother and neonate with alloimmune and autoimmune thrombocytopenia are discussed and current recommendations provided. This document is likely to require frequent future revision(s). 相似文献
2.
It has been previously demonstrated that the generation of measles virus (MV)-specific cytotoxicity (CTL) is reduced in patients with multiple sclerosis (MS). By contrast, CTL specific for influenza virus (FLU) and mumps virus is normal. It is uncertain if reduced CTL is limited to MV in MS patients, or if reduced CTL may be found to other viruses as well. Since MV-specific CTL is predominantly restricted by HLA class II molecules, while FLU-specific and mumps-specific CTL have large HLA class I-restricted components, reduced MV-specific CTL may reflect a broader reduction in HLA class II-restricted CTL in patients with MS. To examine this question we studied the generation of CTL specific for herpes simplex virus type I (HSV). HSV-specific CTL, like MV-specific CTL is predominantly restricted by HLA class II molecules. We found that patients with MS had reduced generation of CTL to both MV and HSV. Most, but not all patients who had reduced generation of CTL to one virus also had a similar impairment with respect to the second virus. Some patients, however, had a reduction in the generation of CTL only to MV or to HSV. These findings extend our earlier observations regarding reduced MV-specific CTL in patients with MS to a second HLA class II-restricted virus, HSV. Such a reduction may reflect discrete impairments in immune function to separate viruses, possibly those that are associated with viral persistence, or may reflect a more generalized defect in HLA class II-restricted CTL. 相似文献
3.
4.
5.
可逆性胆硷酯酶抑制剂二甲氨基甲酸-5-二氢吲哚酯的合成 总被引:1,自引:0,他引:1
为了深入研究催醒宁类化合物的结构与抑酶活性的关系,设计合成了-系列1-,3-或5-位不同取代的二氢吲哚类衍生物(中间体和终产物共24个新化合物)。中间体1,3-二甲基-5-烷氧基-2-二氢吲哚酮(A)的C3烷化。采用相转移催化方法进行;反应中还分离到三个副产物(Ⅶ~Ⅸ)。初筛结果表明:这些化合物大多有较强的抑酶活性;1,3-或5-位取代基的改变均明显影响其活性。 相似文献
6.
Braffman BH; Coleman BG; Ramchandani P; Arger PH; Nodine CF; Dinsmore BJ; Louie A; Betsch SE 《Radiology》1994,190(3):797
7.
Kim McFarland 《Journal of public health dentistry》2002,62(4):224-224
8.
9.
10.
S A Pearlman R S Meek F S Cowchock J B Smith J McFarland R H Aster 《American journal of perinatology》1992,9(5-6):448-451
We report a case of neonatal alloimmune thrombocytopenia and intracranial hemorrhage in an infant whose mother received immunizations of paternal mononuclear cells. This therapy is designed to prevent unexplained first trimester miscarriages. No previous cases of platelet autoimmunization associated with maternal immunization with paternal mononuclear cells has been reported. Treatment with antenatal maternal infusions of intravenous gamma globulin (IVGG) did not prevent fetal thrombocytopenia, but IVGG may become the treatment of choice for postnatal, antibody-mediated thrombocytopenia of the newborn. 相似文献